Viewpoint Capital Management LLC Increases Position in The Clorox Company (NYSE:CLX)

Viewpoint Capital Management LLC lifted its holdings in shares of The Clorox Company (NYSE:CLXFree Report) by 15.3% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The firm owned 9,642 shares of the company’s stock after buying an additional 1,280 shares during the period. Viewpoint Capital Management LLC’s holdings in Clorox were worth $1,566,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently made changes to their positions in the stock. Brooklyn Investment Group increased its holdings in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after purchasing an additional 95 shares during the period. Prospera Private Wealth LLC purchased a new position in Clorox during the 3rd quarter valued at about $27,000. Continuum Advisory LLC raised its position in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after acquiring an additional 138 shares during the last quarter. Carolina Wealth Advisors LLC acquired a new position in Clorox during the third quarter worth about $48,000. Finally, Friedenthal Financial acquired a new stake in shares of Clorox in the third quarter valued at approximately $49,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.

Clorox Trading Up 0.9 %

Shares of NYSE:CLX opened at $148.47 on Wednesday. The stock has a market capitalization of $18.38 billion, a PE ratio of 40.56, a P/E/G ratio of 2.52 and a beta of 0.42. The company has a current ratio of 0.94, a quick ratio of 0.62 and a debt-to-equity ratio of 20.52. The firm has a fifty day moving average price of $160.68 and a 200 day moving average price of $159.16. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $171.37.

Clorox (NYSE:CLXGet Free Report) last announced its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, beating the consensus estimate of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the prior year, the business posted $2.16 earnings per share. Analysts expect that The Clorox Company will post 7.15 EPS for the current fiscal year.

Clorox Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Shareholders of record on Wednesday, January 29th will be issued a $1.22 dividend. This represents a $4.88 dividend on an annualized basis and a yield of 3.29%. The ex-dividend date of this dividend is Wednesday, January 29th. Clorox’s dividend payout ratio (DPR) is presently 133.33%.

Analyst Ratings Changes

A number of brokerages have issued reports on CLX. Wells Fargo & Company raised their price target on Clorox from $157.00 to $161.00 and gave the stock an “equal weight” rating in a research note on Tuesday, February 4th. Royal Bank of Canada reissued a “sector perform” rating and issued a $150.00 target price on shares of Clorox in a research report on Thursday, January 30th. Evercore ISI lifted their price target on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. StockNews.com downgraded Clorox from a “buy” rating to a “hold” rating in a report on Sunday, January 5th. Finally, Barclays lifted their target price on Clorox from $130.00 to $140.00 and gave the company an “underweight” rating in a report on Wednesday, February 5th. Four analysts have rated the stock with a sell rating, eleven have issued a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, Clorox presently has a consensus rating of “Hold” and a consensus target price of $158.21.

View Our Latest Analysis on Clorox

Clorox Company Profile

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Recommended Stories

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.